Novartis India Q2 net up 18 percent at Rs 26 crore
New Delhi: Drug firm Novartis India reported a 17.60 percent rise in its net profit to Rs 26.12 crore for the quarter ended September 30, 2017.
The company had posted a net profit of Rs 22.21 crore for the corresponding period of the previous fiscal, Novartis India said in a filing to the BSE.
In a separate filing, the company announced the resignation of its vice chairman and managing director Ranjit Shahani with effect from February 28, 2018.
Shahani informed the board of directors at a meeting held today of his decision to step down from the office of vice chairman and managing director effective February 28, 2018 (close of business hours) after 20 years of distinguished service with the company, the statement said.
Total income of the company, however, stood at Rs 192.75 crore for the quarter under consideration. It was Rs 194.21 crore for the same period a year ago, Novartis India said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd